Fluoroscopy Equipment Market size was valued at USD 6.13 billion in 2022 and is projected to grow from USD 7.1 billion in 2023 to USD 11.01 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.38% during the forecast period (2023 - 2032).
Rising demand for minimally invasive surgeries, growing incidence of cardiovascular diseases, and advancements in imaging technology are propelling the growth of the market.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
In July 2024, SBM Offshore and Technip Energies formed a partnership. In July 2024, the Gibraltar Health Authority introduced advanced equipment capable of providing immediate diagnostic imaging. This technology will enhance patient care and offer a previously unavailable service at St Bernard's Hospital. Phillips, the business with whom the GHA has a contract, delivered the equipment. St Bernards is experiencing the beginning of numerous promising advancements in the field of diagnostic kits and medical equipment. This is cutting-edge equipment that has been offered. Furthermore, it enables their medical practitioners to make more informed assessments regarding the necessary care and treatment following the completion of the X-ray procedure. The fluoroscopy suite at the GHA will play a crucial role in various important procedures, such as Barium Swallow and Barium Enema. These procedures are essential for monitoring the digestive system and aiding in the diagnosis of problems such as blockages, tumors, and other anomalies inside the gastrointestinal tract. Ekwil is a joint venture focused on floating offshore wind (FOW) with an equal ownership split of 50/50. The objective is to provide a wide variety of FOW (Floating Offshore Wind) solutions that are suitable for mass production in order to meet the energy requirements of clients worldwide. Ekwil, a company based in France, combines Technip Energies' Semi-submersible INO15 with SBM's Tension Leg Platform Float4Wind. The organization has a central staff of 40 experts that receive assistance from SBM/Technip Energies for the implementation of projects
In recent years, minimally invasive procedures have witnessed a robust demand due to the smaller incisions compared to traditional open surgeries, faster recovery, and shorter hospital stays. These procedures cover a broad range of medical applications, such as orthopedic surgery, pain management, and cardiovascular interventions, all of which rely on fluoroscopy technology for real-time imaging guidance. Patients are also choosing minimally invasive techniques more frequently as technological developments improve the accuracy and efficacy of these operations. The demand for modern fluoroscopy technology that can seamlessly integrate into these procedures and provide enhanced visualization, accuracy, and patient safety is being driven by this trend, which is also changing clinical practice. The increased acceptance of minimally invasive procedures is anticipated to maintain the momentum of the fluoroscopy equipment market's expansion as healthcare continues to prioritize patient outcomes and well-being.
Furthermore, cardiovascular diseases, including coronary artery diseases and congenital heart defects, are leading causes of morbidity and mortality worldwide. As per the World Health Organization (WHO), approximately 17.9 million people died from cardiovascular diseases in 2019 globally. Additionally, as per the Centers for Disease Control and Prevention, about 659,000 people die of heart disease in the US every year. Fluoroscopy equipment is extensively used for cardiac catheterization, angiography, and other cardiovascular interventions. Thus, the rising prevalence of cardiovascular diseases, the growth of medical tourism in certain regions, and the development of healthcare infrastructure in emerging economies are also likely to boost the market growth during the forecast period.
The Fluoroscopy Equipment Market is segmented, based on product, into fluoroscopy devices and c-arms. The C-arms is further segmented into mini c-arms, full-size c-arms, and compact c-arms. The fluoroscopy devices segment held the majority share of the market, with a market share of approximately 40–55% in 2022, and C-arms is the fastest-growing segment during the forecast year. The key drivers of the fluoroscopy devices segment's growth are an increase in the adoption of fluoroscopic devices, a rise in the prevalence of cardiovascular diseases, and an increase in R&D spending on improving fluoroscopic equipment drives the segment growth.
FIGURE 2: FLUOROSCOPY EQUIPMENT MARKET, BY PRODUCT, 2022 & 2032 (USD BILLION)
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
On the basis of application, the Fluoroscopy Equipment Market has been segmented into orthopedic, cardiovascular, pain management & trauma, neurology, gastrointestinal, urology, general surgery, and others including Ear, Nose, and Throat (ENT) among others. The cardiovascular segment held the largest market share in 2022 and orthopedic is the fastest-growing segment during the forecast year. This is owing to the increasing incidences of cardiovascular diseases across the globe, which is increasing the demand for fluoroscopy equipment to visualize blood vessels and guide catheter-based interventions in cardiology. From angioplasties to stent placements, fluoroscopy assists in intricate cardiovascular procedures, contributing to improved patient outcomes. Simultaneously, the orthopedic segment emerges as one of the most rapidly expanding segments, driven by the increasing need for precision in musculoskeletal interventions.
Based on end user, the Fluoroscopy Equipment Market has been segmented into hospitals & clinics, diagnostic centers, and others including ambulatory surgical centers among others. The hospitals & clinics companies segment dominated the market in the base year, i.e., 2022, and the diagnostic centers segment is the fastest-growing segment during the forecast period, 2023–2032. Furthermore, the factors influencing the growth of the hospitals & clinics segment are rising incidences of chronic diseases such as cardiovascular conditions, orthopedic disorders, & gastrointestinal issues and patient preferences for modern healthcare. Moreover, the rising focus on advanced imaging services, accurate diagnoses, and convenient accessibility has propelled the growth of diagnostic centers and solidified their significance in modern healthcare.
By region, the study segments the market into North America, Europe, Asia-Pacific, and the rest of the world. In North America, the fluoroscopy equipment market held the largest market share in 2022 due to the presence of major players in the US such as General Electric Company (US) and Hologic Inc. (US). In addition, technological innovation and high healthcare expenditure foster market growth. Additionally, the growing number of neurological disorders, such as brain tumors among others, is also expected to boost market growth. For instance, according to the National Brain Tumor Society (NBTS), primary brain tumor affects around 700,000 people in the US, and 88,970 more diagnosed in 2022. Hence, the presence of major players in the region and increasing incidences of neurological disorders are fostering the North America fluoroscopy equipment market growth.
Further, the major countries studied are: The US, Canada, France, Germany, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
FIGURE 3: FLUOROSCOPY EQUIPMENT MARKET, BY REGION, 2022 & 2032 (USD BILLION)
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
The Europe fluoroscopy equipment market accounted for the second-largest market share due to the increasing prevalence of chronic diseases and the rising aging population. As the elderly population grows, the incidence of conditions like cardiovascular diseases, orthopedic issues, and gastrointestinal disorders increases, necessitating the use of fluoroscopy for accurate diagnoses and effective treatments. For instance, according to Eurostat, the population of individuals aged 65 years and above is approximately 90.5 million in 2019 and is projected to reach nearly 129.8 million by 2050. Moreover, the emphasis on radiation dose reduction is a prominent trend in the market. Regulatory bodies and healthcare professionals are focusing on minimizing patient and staff radiation exposure during procedures. This has led to the development of advanced imaging technologies that provide high-quality images with lower radiation doses, contributing to the market's growth. Furthermore, the Germany fluoroscopy equipment market held the largest market in 2022, and the UK fluoroscopy equipment market is projected to be the fastest-growing market in the Europe region.
The Asia-Pacific fluoroscopy equipment market is the fastest growing region from 2023 to 2032, owing to the rapid expansion of healthcare infrastructure in the region and the rising burden of non-communicable diseases such as cardiovascular diseases, cancer, & orthopedic disorders in Asia-Pacific countries. Additionally, the demand for minimally invasive procedures is on the rise, as patients and healthcare providers seek alternatives to traditional surgical methods. Fluoroscopy's role in guiding such procedures is contributing to market growth. Moreover, the Japan fluoroscopy equipment market accounted for the largest market share in 2022, and the India fluoroscopy equipment market is projected to be the fastest-growing market in the Asia-Pacific region.
Major market players are investing heavily in R&D in order to expand their service offerings, which helps in driving the fluoroscopy equipment market growth. Market participants are also expanding their global footprint through various strategic initiatives such as new product launches, contractual agreements, mergers & acquisitions, investments, and collaboration with other market players.
Siemens Healthineers (Germany) is a global medical technology company that specializes in providing innovative solutions in the fields of medical imaging, laboratory diagnostics, and advanced healthcare IT. With a commitment to improving patient care and healthcare outcomes, the company offers a wide range of products and services, including diagnostic imaging systems, clinical laboratory equipment, point-of-care testing devices, and digital healthcare solutions. The company's cutting-edge technologies and comprehensive portfolio aim to empower healthcare professionals with accurate diagnostics, efficient workflow solutions, and patient-centered care. Furthermore, in September 2021, Siemens Healthineers (Germany) launched the Luminos Impulse fluoroscopy system with features including a seamless imaging chain, complete dosage optimization, cybersecurity features, and detector-sharing options for radiography.
Key Companies in the Fluoroscopy Equipment Market includes.
Fluoroscopy Equipment Industry Developments
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)